Cargando…
Insidious Insights: Implications of viral vector engineering for pathogen enhancement
Optimizing viral vectors and their properties will be important for improving the effectiveness and safety of clinical gene therapy. However, such research may generate dual-use insights relevant to the enhancement of pandemic pathogens. In particular, reliable and generalizable methods of immune ev...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191845/ https://www.ncbi.nlm.nih.gov/pubmed/35264741 http://dx.doi.org/10.1038/s41434-021-00312-3 |
_version_ | 1785043539950829568 |
---|---|
author | Sandbrink, Jonas B. Alley, Ethan C. Watson, Matthew C. Koblentz, Gregory D. Esvelt, Kevin M. |
author_facet | Sandbrink, Jonas B. Alley, Ethan C. Watson, Matthew C. Koblentz, Gregory D. Esvelt, Kevin M. |
author_sort | Sandbrink, Jonas B. |
collection | PubMed |
description | Optimizing viral vectors and their properties will be important for improving the effectiveness and safety of clinical gene therapy. However, such research may generate dual-use insights relevant to the enhancement of pandemic pathogens. In particular, reliable and generalizable methods of immune evasion could increase viral fitness sufficient to cause a new pandemic. High potential for misuse is associated with (1) the development of universal genetic elements for immune modulation, (2) specific insights on capsid engineering for antibody evasion applicable to viruses with pandemic potential, and (3) the development of computational methods to inform capsid engineering. These risks may be mitigated by prioritizing non-viral delivery systems, pharmacological immune modulation methods, non-genetic vector surface modifications, and engineering methods specific to AAV and other viruses incapable of unassisted human-to-human transmission. We recommend that computational vector engineering and the publication of associated code and data be limited to AAV until a technical solution for preventing malicious access to viral engineering tools has been established. |
format | Online Article Text |
id | pubmed-10191845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101918452023-05-19 Insidious Insights: Implications of viral vector engineering for pathogen enhancement Sandbrink, Jonas B. Alley, Ethan C. Watson, Matthew C. Koblentz, Gregory D. Esvelt, Kevin M. Gene Ther Perspective Optimizing viral vectors and their properties will be important for improving the effectiveness and safety of clinical gene therapy. However, such research may generate dual-use insights relevant to the enhancement of pandemic pathogens. In particular, reliable and generalizable methods of immune evasion could increase viral fitness sufficient to cause a new pandemic. High potential for misuse is associated with (1) the development of universal genetic elements for immune modulation, (2) specific insights on capsid engineering for antibody evasion applicable to viruses with pandemic potential, and (3) the development of computational methods to inform capsid engineering. These risks may be mitigated by prioritizing non-viral delivery systems, pharmacological immune modulation methods, non-genetic vector surface modifications, and engineering methods specific to AAV and other viruses incapable of unassisted human-to-human transmission. We recommend that computational vector engineering and the publication of associated code and data be limited to AAV until a technical solution for preventing malicious access to viral engineering tools has been established. Nature Publishing Group UK 2022-03-10 2023 /pmc/articles/PMC10191845/ /pubmed/35264741 http://dx.doi.org/10.1038/s41434-021-00312-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Perspective Sandbrink, Jonas B. Alley, Ethan C. Watson, Matthew C. Koblentz, Gregory D. Esvelt, Kevin M. Insidious Insights: Implications of viral vector engineering for pathogen enhancement |
title | Insidious Insights: Implications of viral vector engineering for pathogen enhancement |
title_full | Insidious Insights: Implications of viral vector engineering for pathogen enhancement |
title_fullStr | Insidious Insights: Implications of viral vector engineering for pathogen enhancement |
title_full_unstemmed | Insidious Insights: Implications of viral vector engineering for pathogen enhancement |
title_short | Insidious Insights: Implications of viral vector engineering for pathogen enhancement |
title_sort | insidious insights: implications of viral vector engineering for pathogen enhancement |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191845/ https://www.ncbi.nlm.nih.gov/pubmed/35264741 http://dx.doi.org/10.1038/s41434-021-00312-3 |
work_keys_str_mv | AT sandbrinkjonasb insidiousinsightsimplicationsofviralvectorengineeringforpathogenenhancement AT alleyethanc insidiousinsightsimplicationsofviralvectorengineeringforpathogenenhancement AT watsonmatthewc insidiousinsightsimplicationsofviralvectorengineeringforpathogenenhancement AT koblentzgregoryd insidiousinsightsimplicationsofviralvectorengineeringforpathogenenhancement AT esveltkevinm insidiousinsightsimplicationsofviralvectorengineeringforpathogenenhancement |